PHARMACEUTICAL COMPOSITION COMPRISING HYDROCHLOROTHIAZIDE, EPROSARTAN AND LERCANIDIPINE… Application WO-2016132193-A1 World Intellectual Property Organisation (WIPO) 25 Aug 2016